We have measured the expression of IDOL in CD14+ monocytes in subjects with and without type 2 diabetes and shown that IDOL expression in CD14+ monocytes was significantly reduced in individuals with diabetes compared with healthy nondiabetic control. This evidence concerns the gene MYLIP and diabetes mellitus.